Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-03-11
1997-01-28
Criares, T. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514449, A61K 3700, A61K 31225
Patent
active
055977987
ABSTRACT:
The present invention comprises a method of sensitizing various types of cancer cells derived from different tissues of origin to various cytotoxic agents and augmenting the sensitivity of cancer cells to these cytotoxic agents. The invention provides a method to treat cancer and other cell proliferative diseases by the administration of a sensitizing agent prior to or concurrently with the administration of a cytotoxic agent.
REFERENCES:
patent: 4571336 (1986-02-01), Houck et al.
patent: 4863902 (1989-09-01), Amagase et al.
patent: 4925922 (1990-05-01), Byers et al.
patent: 4959353 (1990-09-01), Brown et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 5252342 (1993-10-01), Howell et al.
Bil'din, et al., "Participation of the epirmal growth factor and insulin in the regulation of repair gamma-induced DNA single-strand breaks", Chem. Abs., 106(21):169447(u) (1987).
Myers et al., "Conjugates containing tumor-specific agents, cytotoxic agents and biodegradable polymeric carriers for selective delivery of cytotoxic drugs to tumor cells and methods of destroying tumor cells using the conjugates", Chem. Abs., 109(25):222460 (h). (1989).
Aboud-Pirak, et al., "Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and n nude mice", Chem. Abs., 110(9):69068(k) (1984).
Hirata, et al., "Possible contribution of protein kinase C activation to priming for DNA synthesis induced by epidermal growth factor with insulin and its inhibition by plasma membrane in primary cultured rat hepatocytes", Chem. Abs., 113(21):185362(n) (1990).
Christen, et al., "Epidermal Growth Factor Regulates the In vitro Sensitivity of Human Ovarian Carcinoma Cells To Cisplatin", J. Clin. Invest., 86:1632-1640 (1990).
Aboud-Pirak, et al., "Efficacy of Antibodies to Epidermal Growth Factor Receptor Against KB Carcinoma In Vitro and in Nude Mice", Articles, 80(20):1605-1611 (1988).
Andrews Paul A.
Christen Randolph D.
Howell Stephen B.
Isonishi Seiji
Criares T. J.
Dreger Walter H.
The Regents of the University of California
LandOfFree
Taxol and epidermal growth factor used to enhance treatment of o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Taxol and epidermal growth factor used to enhance treatment of o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taxol and epidermal growth factor used to enhance treatment of o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941502